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In recent years, exploration of the brain extracellular space (ECS) has made remarkable
progress, including nanoscopic characterizations. However, whether ECS precise conforma-
tion is altered during brain pathology remains unknown. Here we study the nanoscale
organization of pathological ECS in adult mice under degenerative conditions. Using electron
microscopy in cryofixed tissue and single nanotube tracking in live brain slices combined with
super-resolution imaging analysis, we find enlarged ECS dimensions and increased nanoscale
diffusion after α-synuclein-induced neurodegeneration. These animals display a degraded
hyaluronan matrix in areas close to reactive microglia. Furthermore, experimental hyaluronan
depletion in vivo reduces dopaminergic cell loss and α-synuclein load, induces microgliosis
and increases ECS diffusivity, highlighting hyaluronan as diffusional barrier and local tissue
organizer. These findings demonstrate the interplay of ECS, extracellular matrix and glia in
pathology, unraveling ECS features relevant for the α-synuclein propagation hypothesis and
suggesting matrix manipulation as a disease-modifying strategy.
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The brain extracellular microenvironment is the activemilieu surrounding cellular membranes in the centralnervous system (CNS). It is composed by a dynamic
compartment, the extracellular space (ECS), which contains the
interstitial fluid and a plastic scaffold known as the extracellular
matrix (ECM). The ECS provides a reservoir of ions to support
membrane and action potentials, playing a fundamental role in
the diffusion of chemical signals and intercellular communica-
tion1–3. Additionally, the ECS is thought to be implicated in the
large-scale advection of molecules by determining the bulk flow
of interstitial fluid4,5, possibly through convective or local flow6.
With a width down to the nanometer range, the ECS has
remained a black box in neuroscience until very recently7, and
imaging the adult brain ECS is still a challenging endeavor.
The main structural component of the brain ECS is the
ECM, a dense network of macromolecules secreted by glia and
neurons8. Unlike the ECM from connective tissue, where
collagen is the main unit, the neural interstitial matrix mainly
consists of long chains of the glycan polymer hyaluronan9.
Other ECM components bind to large hyaluronan molecules
forming a self-assembled matrix that functions as cell-
attaching scaffold and maintains the patency of the ECS,
influencing its organization at a multilevel scale7.
Interestingly, hyaluronan has also manifold signaling proper-
ties depending on its size10. High-molecular weight-hyalur-
onan (HMW-HA) elicits anti-inflammatory and anti-
proliferative responses, whereas short hyaluronan fragments
activate pro-inflammatory pathways in specific cells such as
microglia11. Although the function of ECM during CNS
development and plasticity is well documented, major ques-
tions remain about its involvement in the pathophysiology of
the mature brain12.
The implications of this complex extracellular system on the
etiology and progression of brain disorders remain
largely underexplored. While limited information on ECM
dynamics exists in selected neuropathologies such as multiple
sclerosis and stroke, data on Parkinson’s disease (PD) or other
proteinopathies is scarce12,13. Furthermore, as we enter the
realm of super-resolved ECS exploration14, our data on the
pathological brain ECS is incomplete. In healthy tissue, ECS
nanoscale topology has been described both in cryofixed15–17
and live samples18. Moreover, we have recently reported the
ECS local nanoscale organization and diffusivity on young2
and adult live brain19 using single-walled carbon nanotubes
(SWCNTs) as super-resolution imaging probes. Whether these
parameters change during disease states and whether an
interplay exists between the ECS and the pathological process
is still unknown.
Here we report on the dynamics and organization of the
brain extracellular microenvironment in a PD pathological
context, using a combination of state-of-the-art imaging
approaches and an established in vivo model of α-synuclein (α-
syn)-induced dopaminergic neurodegeneration20,21, a proxy of
synucleinopathy leading to PD. We describe profound altera-
tions in ECS morphological and diffusional parameters in the
substantia nigra of parkinsonian mice at nanometer resolution.
We further characterize the pathological ECS by exploring the
status of the hyaluronan network in vivo, its relation with
reactive microglia and inflammation, and dopaminergic cell
loss and ECS parameters after acute and chronic hyaluronan
depletion. Our results reveal an interplay between ECS, ECM,
and neurodegeneration, shedding light upon a neglected
compartment for the diffusion of aggregated α-synuclein seeds.
This integrative study explores the pathological extracellular
microenvironment as a whole in adult brain tissue, and paves
the way to explore the ECS in other models of proteinopathies.
Results
α-syn-induced neuronal loss enlarges the extracellular space.
To investigate the ECS in a context of neurodegeneration, we
employed a unique paradigm of α-syn-induced dopaminergic
neuronal loss by unilateral inoculation of Lewy body (LB) frac-
tions derived from PD patients into the substantia nigra (SN) of
adult mice20,21. Control animals received fractions containing
only soluble α-syn (noLB), while the LB fractions contained α-syn
seeds in its aggregated form. Stereological cell counts of tyrosine
hydroxylase (TH) immunostaining confirmed 47% nigral dopa-
minergic degeneration (ipsi/contra TH-positive cell ratio: 0.96 ±
0.05 noLB, 0.53 ± 0.05 LB) 4 months after LB inoculation (Fig. 1a,
b and Supplementary Fig. 1), a similar rate to the histopatholo-
gical features of this model, that have been extensively described
elsewhere20,21.
Electron microscopy (EM) has been historically used to study
the topology of brain tissue at sub-micron resolution. However,
ultrastructural analysis of the ECS has proven difficult to
implement due to dehydration during fixation and sample
processing, which shrinks the ECS and underestimates its size.
While isotonic membrane-impermeant buffers have been used to
overcome this artifact with relative success22,23, cryofixation
studies have shown effective ECS preservation in cerebellum15
and mouse neocortex16,17. We, therefore, used cryofixation of
brain tissue rapidly removed from LB-inoculated mice to reveal
the ECS in the SN. High-pressure cryofixation prevents formation
of ice crystals and membrane rupture and freeze-substitution
resin embedding retains molecules in their hydrated positions,
effectively preserving the extracellular space when compared to
classical aldehyde fixation (Fig. 1c). The result is a more accurate
representation of the ECS, where key elements of the neuropil
retain their physiological dimensions (Supplementary Fig. 2a).
This preparation was able to preserve ECS heterogeneity as we
could discern, for instance, compact intermembrane gaps at the
synaptic cleft as well as large perisynaptic spaces surrounding
them (Supplementary Fig. 2b, c). Details were sufficiently clear to
delineate the ECS and resolve extracellular gaps of 20 nm width
(Supplementary Fig. 2d).
With this tool in hand, we quantitatively analyzed the ECS
dimensions in the SN of control and LB-inoculated mice. After
the manual segmentation of EM ultramicrographs, we calculated
the relative ECS area (Fig. 1d). This estimation of ECS volume
fraction (defined as α in previous studies) showed variations in
the SN between 15% and 24%, in accordance with previously
reported α values for other brain regions in mice1. There was a
clear tendency for larger ECS volume fractions in the SN of LB-
inoculated mice (16.8 ± 1.1% noLB, 20.0 ± 1.0% LB; Fig. 1e)
although the difference regarding control nearly achieved
statistical significance (P= 0.064). Since volume fraction is a
global parameter that takes into account the region sampled as a
whole, to take advantage of the nanometric resolution achieved
by EM we next explored local geometric variations by analyzing
individual 2D compartments in binary images of the ECS
(Fig. 1d). Skeletonization revealed heterogeneous lengths, detect-
ing significantly longer ECS compartments in parkinsonian mice
when compared to control (0.52 ± 0.05 µm noLB, 0.70 ± 0.12 µm
LB; Fig. 1f). Analysis of 2D-local thickness identified larger ECS
widths in the SN of LB-inoculated mice when compared to
control (112 ± 7 nm noLB, 140 ± 6 nm LB; Fig. 1g). Mapping local
ECS widths yielded diverse geometries, where large pools with
diameters around 200 nm are connected by narrow channels of
less than 100 nm width (Fig. 1h). The distribution of ECS widths
was positively skewed, with ~50% values under 100 nm (Fig. 1i).
Differences were greater in the larger dimensions (>200 nm), as
the SN of LB-inoculated mice displayed twice the number of large
pools than control animals (11.83% noLB, 20.61% LB; Fig. 1j).
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Thus, neurodegeneration would affect how the ECS volume
fraction is spatially distributed, rather than the volume fraction
per se.
Synucleinopathy increases extracellular space diffusivity.
Molecular mobility through the ECS is key to important phy-
siological events, such as signal transmission or ion concentra-
tion24. Hence, determining live ECS local diffusive environment is
as essential as knowing its dimension. We have recently used
single-molecule tracking of fluorescent SWCNTs to quantitatively
visualize nanoscale dimensions and diffusivity in the adult mouse
ECS by near-infrared (NIR) imaging19. Here, we used acute slices
of LB-inoculated mice (i.e., 4 months post-inoculation) 1 h after
in vivo injection of SWCNTs to explore local ECS parameters in a
neurodegenerative context (Fig. 2a, b). As non-internalizable ECS
fluorescent probes of large aspect-ratio2, Brownian motion of
SWCNTs is effectively constrained by brain ECS geometry and
composition with respect to free medium (Supplementary
Movie 1). SWCNTs exceptional photostability enables long-term
acquisitions with negligible decrease in fluorescence (Supple-
mentary Movie 2). However, since they rarely remain confined to
a specific area, individual acquisitions of 5–10 min were per-
formed. Single-molecule localization allowed for sub-wavelength
(~50 nm) tracking of SWCNTs and provided super-resolution
analysis of ECS dimensions. In addition, iterative analysis of finite
time-windows rendered instantaneous relative diffusivity (Dinst/
Dref) maps of the nigral ECS with nanoscale precision (Supple-
mentary Fig. 3).
Local instantaneous diffusivity maps revealed a diverse ECS in
both healthy and degenerative SN, where diffusional patterns
change drastically within few nanometers (Fig. 2c and Supple-
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Fig. 1 α-syn-induced neurodegeneration enlarges the extracellular space locally. a Experimental timeline of the mouse model of Lewy body (LB)-induced
neurodegeneration. b TH stereological cell counts confirmed 40% dopaminergic cell loss typically observed in the SN of LB-inoculated mice (paired two-
tailed Student’s t test, n= 6 mice). c Ultramicrographs of cryofixed (left) vs chemically fixed (right) brain tissue (ECS is pseudo-colored). Classic
glutaraldehyde fixation artefactually reduces ECS size, whereas high-pressure cryofixation represents more accurately ECS dimensions. Scale bar, 1 µm.
d Schematic diagram of cryofixation, freeze-substitution, EM and image analysis protocol. e ECS volume fraction in the SN of LB and noLB-mice (two-tailed
Student’s t test, n= 6 SNs). f, g Mean and cumulative distribution of ECS compartment lengths (f) and local widths (g) in the SN after LB-induced
neurodegeneration (Two-tailed Student’s t test and Kolmogorov–Smirnov test, n= 6 SNs). h ECS local width maps from Ctrl and LB-inoculated mice
display the characteristic channels-and-pools configuration of the ECS, revealing increased dimensions in the degenerated SN. Scale bar, 1 µm. i Distribution
of ECS local widths from all maps generated in the study. j Proportions of ECS compartments categorized by width (Large pools, >200 nm; small pools,
100–200 nm; channels, <100 nm) expressed as % of ECS (Chi-square test) showing that LB-induced neurodegeneration affects how the ECS is spatially
distributed. Error bars represent mean ± SEM. Source data are provided as a Source data file. See also Supplementary Figs. 1 and 2.
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configurations: long explorations spanning several µm, with ECS
channels connected by pools in a similar fashion to EM images
(Supplementary Fig. 4a), and spatially restricted compartments
where SWCNTs move within the same domain (Supplementary
Fig. 4b). Quantitative analysis detected a highly constrained ECS
in the control SN, where SWCNT movement was hindered more
than 10-fold respect to free medium (Dinst/Dref median= 0.026,
IQR= 0.017-0.038; Fig. 2d, e). On the contrary, in LB-inoculated
mice we observed increased local diffusivity respect to control,
with a significant proportion of values falling within the 0.1–0.2
range (median= 0.042, IQR= 0.021−0.080; Fig. 2d, e). Further-
more, in LB-exposed animals, SWCNTs exploration covered a
significantly broader ECS area within the same time-frame (6.2 ±
1.4 µm2 noLB, 16.2 ± 4.0 µm2 LB; Supplementary Fig. 4c and
Supplementary Movie 3). These results indicate increased ECS
nanoscale diffusion after LB-induced neurodegeneration.
In a similar fashion to traditional ECS diffusional studies25,
single SWCNT trajectories can reveal the nanoscale geometry of
the compartment explored by applying a super-resolution
microscopy methodology. Dimensional maps in the live brain
(Fig. 2f) confirmed the nanoscale channels-and-pools ECS
configuration, whereas quantitative analysis corroborated EM
results, revealing increased local ECS widths after LB-induced
neurodegeneration (median= 114 nm, IQR= 76–170 nm noLB,
median= 119 nm, IQR= 75–187 nm LB; Fig. 2g, h). Interest-
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Fig. 2 Single-nanotube tracking reveals increased ECS nanoscale diffusivity and width after synucleinopathy. a Experimental timeline. b Schematic
diagram of SWCNT imaging and tracking setup. Fluorescent SWCNTs are administered in vivo into the lateral ventricle of adult mice and allowed to diffuse
into the brain for 1 h. Acute brain slices are imaged at 37 °C using a NIR fluorescence microscope equipped with an EM-CCD camera. c ECS instantaneous
relative diffusivity maps reveal a heterogeneous ECS in the SN, with increased nanoscale diffusion after LB-induced neurodegeneration. Scale bar, 2 µm.
d, e Frequency (d) and cumulative (e) distributions of local relative diffusivity values (Dinst/Dref) in the nigral ECS indicate augmented nanoscale diffusion in
the parkinsonian SN (Kolmogorov–Smirnov test, n= 4 mice). f Maps of local ECS dimensions in the SN of noLB and LB-inoculated mice, corroborating in
live brain the channels-and-pools configuration observed in cryofixed tissue. Scale bar, 2 µm. g, h Frequency (g) and cumulative (h) distributions of local
ECS dimensions show increased ECS width in LB-inoculated mice (Kolmogorov–Smirnov test, n= 4 mice). i–k Insets from (c, f). Increased diffusion is not
always correlated to enlarged dimensions, suggesting that inhomogeneous diffusion is not only dependent on environmental geometry. l Scatter plot of all
trajectories showing weak correlation between both parameters. Source data are provided as a Source data file. See also Supplementary Figs. 3 and 4.
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diffusivity (Pearson’s r= 0.195 noLB, 0.353 LB; Fig. 2i–l),
suggesting that spatial constriction is not necessarily the central
determinant of ECS diffusion inhomogeneities at the nanoscale.
Synucleinopathy induces degradation of the hyaluronan
matrix. The main diffusional barrier in the brain ECS is the
neural interstitial matrix1,24. As its main scaffolding molecule,
changes in hyaluronan (HA) content can dramatically alter other
ECM components26 and consequently ECS parameters2,27. We,
therefore, analyzed the status of the HA network in the mouse SN
after LB-induced neurodegeneration by confocal microscopy.
Hyaluronic acid-binding protein (HABP) staining in the murine
SN was more intense than in surrounding regions, but the
staining pattern differed between subareas (Supplementary
Fig. 5a). The substantia nigra pars compacta (SNc), which harbors
packed dopaminergic neurons projecting mainly to the striatum,
presented a dense interstitial HA matrix (Supplementary Fig. 5b).
In the substantia nigra pars reticulata (SNr), which contains
dendrites radiating from the SNc and scattered GABAergic
neurons, HA staining was more disperse but especially intense in
the perineuronal nets (PNNs; Supplementary Fig. 5b).
This precise organization was substantially altered after LB-
induced neurodegeneration. The interstitial matrix appeared
more diffuse, and the HA cable-like structures often described
in literature28 were limited to dispersed dots (Fig. 3a, b). Despite
neurodegeneration and HA disruption, chondroitin-sulfate pro-
teoglycans (CSPGs) appeared unaffected as observed by the
archetypical staining of PNNs by Wisteria Floribunda Agglutinin
(WFA; Fig. 3c), as reported by others29–31. Quantification
detected decreased HA immunostaining in the SN of LB-
inoculated mice compared to control (3.3 ± 0.4% vs 6.3 ± 1.2%;
Fig. 3d). Morphological analysis revealed shorter HA cables in
LB-inoculated mice (median= 0.48 µm noLB, 0.34 µm LB;
Fig. 3e). Despite HA being a linear polysaccharide, it appears as
an interconnected network thanks to cross-linking by hyalectans
and tenascins, forming supramolecular complexes of varying
stability32. Measuring HA cross-linking provide, thus, an
estimation of matrix interconnectivity and organization. We,
therefore, quantified HA network complexity by fractal analysis
(Db)33 and detected lower values in LB-inoculated mice (1.53 ±
0.04% noLB, 1.35 ± 0.05% LB; Fig. 3f), indicating decreased HA
network complexity in the degenerated SN.
To investigate the basis for HA disruption, we next analyzed
mRNA expression of genes related to HA synthesis/catabolism in
ventral midbrain homogenates from control and LB-inoculated
mice. We detected no differences in mRNA expression of HA
synthases (Has) or hyaluronidases (Hyal). Since HA catabolism
also depends on receptor-mediated endocytosis34, we examined
mRNA levels of HA receptors. We found increased expression of
CD44 (2.6 ± 0.4-fold; Fig. 3g), the main HA receptor, expressed
mostly in glia and associated with inflammation in the CNS10,35.
Additionally, we tested several glia and inflammation-related
genes (Fig. 3h), detecting a significant increase in mRNA levels of
microglia/macrophage activation marker CD68 (1.6 ± 0.1-fold
change) and pro-inflammatory cytokine TNF-α (5.7 ± 1.8-fold
change), indicate ongoing inflammation in the SN after LB-
induced neurodegeneration.
Reactive microglia engulf hyaluronan after synucleinopathy.
Whereas reactive microglia has been described in several PD
animal models, experimental data on non-transgenic α-synuclein-
based PD models is scarce36. We, therefore, characterized the
microglial phenotype after LB-induced neurodegeneration by
immunohistochemistry. In control mice, Iba1 immunostaining
was restricted mostly to the SNr, with few microglial somas in the
SNc (Fig. 4a, b), as described in literature37. This pattern was
substantially altered in LB-inoculated mice, with more than
twofold microglial cells (132 ± 14 noLB, 267 ± 29 LB; Fig. 4c) and
a b c







































































































































































Fig. 3 The hyaluronan matrix is degraded after synucleinopathy. a Confocal micrographs from the SN of noLB and LB-inoculated mice, showing a
widespread disruption of the matrix in the degenerated SN and fewer cable-like HA structures. Scale bar, 50 µm. b Binary and skeletonized images of the
HA network used to quantify HA matrix disruption. Note the dotted, degraded pattern of HA in the degenerated SN. Scale bar, 50 µm. c WFA staining in
the SN of LB-inoculated mice reveals no disruption of CSPGs. Scale bar, 50 µm. Color bar represents fluorescence intensity. d HA levels are decreased in
the SN of LB-inoculated mice (two-tailed Student’s t test, n= 6 mice). e Cumulative distributions of HA skeleton lengths indicate shorter cable-like
structures after LB-induced neurodegeneration (Kolmogorov–Smirnov test, n= 6 mice). f Fractal dimension analysis of the HA network shows disrupted
matrix interconnectivity in the parkinsonian SN (two-tailed Student’s t test, n= 6 mice,). g, h mRNA expression analysis of HA-related genes (g) and
inflammation-related genes (h) in ventral midbrain homogenates of LB and noLB-inoculated mice (two-tailed Student’s t test, n= 4 mice). Error bars
represent mean ± SEM. Source data are provided as a Source data file. See also Supplementary Fig. 5.
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Iba1 staining (1.4 ± 0.3% noLB, 3.2 ± 0.5% LB; Fig. 4c) in the SNc.
Microgliosis was evident in SNc areas depleted of TH-positive
cells, but also in regions where dopaminergic cell loss was milder
(Supplementary Fig. 6a, b).
We next examined the activation status and phagocytic activity
of microglia in a context of nigral matrix degradation by multiple
immunostaining. We detected HA particles engulfed by microglia
in both noLB and LB-inoculated mice (Fig. 4d). HABP staining
inside Iba1-positive cells co-localized with lysosomal marker
CD68 (Fig. 4d, e). Although not all CD68-positive pouches were
positive for HA, both HA-positive and HA-negative pouches
were found in the same cell (Supplementary Fig. 6c, d). Despite
these results suggesting a physiological role of microglia in HA
turnover, the number of microglial cells with HA inclusions was
significantly increased after LB-induced neurodegeneration (23.5
± 3.8% noLB, 66.1 ± 7.2% LB; Fig. 4f), often displaying more than
one HA-positive pouch per cell (Fig. 4d, arrowheads). Finally,
CD68 staining was significantly higher in LB-inoculated mice
(0.43 ± 0.07% vs. 0.10 ± 0.02%; Fig. 4g), confirming qPCR data
and indicating microglial activation in the lesioned SN. Taken
together, these results suggest an involvement of reactive
microglia in HA matrix degradation after LB-induced dopami-
nergic cell loss.
Hyaluronan breakdown is neuroprotective in LB-injected mice.
Having described the consequences of neurodegeneration on the
brain extracellular microenvironment, we next enquired whether
modification of ECS/ECM would alter the pathological process.
Degradation of the HA matrix by intracerebral injection of hya-
luronidase (Hyase) has proven a useful tool to explore ECM
modification in vivo30,38, and we have previously reported its
effect by observing increased ECS nanoscale diffusion in the
rodent brain2. We, therefore, inoculated LB fractions concomitant
with Hyase (or PBS as control) in the murine SN (Fig. 5a). Hyase
did not alter the aggregation status of LB fractions, as observed by
unchanged thioflavin T fluorescence profiles (Supplementary
Fig. 7a). Four months post-inoculation, LB+ PBS group dis-
played 40% neurodegeneration (Fig. 5b–d), similar to the classical
LB-inoculation protocol. In contrast, stereological cell counts
revealed only 20% dopaminergic cell loss in LB+Hyase-inocu-
lated mice (2736 ± 257 cells LB+ PBS, 3957 ± 318 LB+Hyase;
Fig. 5c, d). We noticed fewer Proteinase K (PK)-resistant α-syn
aggregates in LB+Hyase-treated mice (Supplementary Fig. 7b),
although the low number of aggregates rendered any quantifi-
cation futile. To evaluate whether the neuroprotective effect of
Hyase was exclusively related to HA, we co-inoculated LB with
chondroitinase (ChABC) to degrade CSPGs, another ECM
component associated to structural HA. ChABC injection in vivo
effectively removed PNNs in the SN (Supplementary Fig. 8), but
did not alter the typical 0.6 ipsi/contra ratio triggered by LB
(Fig. 5c, d), indicating that Hyase effect is connected to HA
degradation rather than to ECM disorganization. Co-injection of
LB with high-molecular weight HA (HMW-HA) also failed to
reduce LB-induced neurodegeneration (Fig. 5c, d). However,
concomitant injection of LB with low-molecular weight HA
(LMW-HA) ameliorated dopaminergic cell loss to a similar extent
than Hyase treatment (3560 ± 144 cells; Fig. 5c, d), suggesting that
HA breakdown into small fragments is responsible for the neu-
roprotective effect, instead of merely a modification of HA
content.
Hyase effect in the rodent brain lasts only a few days, due to the
high replenishing ratio of HA in vivo which reappears as isolated
patches 3–5 days after injection38. Furthermore, proteopathic
seeding from exogenous α-syn typically occurs within 24 h after
inoculation of LB fractions20. We, therefore, investigated the early
events (72 h) after LB+Hyase inoculation (Fig. 5e). Human
21
noLB LB
Orthogonal projectionsIba1 CD68 HABP DAPI Engulfed hyaluronan
noLB LB





















































































































Fig. 4 Reactive microglia populate the SNc and phagocytes hyaluronan after α-syn-induced neurodegeneration. a, b Confocal images showing
distribution of microglia (Iba1) in the SN of mice. In control animals, microglia populate mostly the SNr and is scarce in the SNc, packed with TH-positive
neurons. This pattern is disrupted in LB-inoculated mice. Scale bars, 50 µm. c Quantification of Iba1-positive cells and Iba1 area in the SNc show microgliosis
in this region after LB-induced neurodegeneration (two-tailed Student’s t test, n= 6 mice). d Orthogonal projections showing HA phagocytosis by
microglia in the murine SN. Engulfed HA co-localizes with lysosomal marker CD68 (arrowheads), although some CD68 dots are negative for HABP
(arrows). Microglia from LB-inoculated mice display more HA inclusions, as seen in this micrograph where up to 4 pouches of engulfed HA can be
observed. Scale bar, 10 µm. e Fluorescence intensity profiles from (d). f Quantification of microglia with HA inclusions in the SN of LB and noLB-mice (two-
tailed Student’s t test, n= 6 mice). g Quantification of CD68 levels indicate microglial activation in the SN of LB-inoculated mice (two-tailed Student’s
t test, n= 6 mice). Error bars represent mean ± SEM. Source data are provided as a Source data file. See also Supplementary Fig. 6.
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α-syn staining was significantly lower in the SN after LB+Hyase
injection in comparison to LB+ PBS (0.08 ± 0.03% vs. 0.21 ±
0.03%; Fig. 5f), indicating reduced patient-derived α-syn load in
Hyase-treated animals. This decrease in α-syn inoculum was
partially reproduced by LMW-HA co-injection, but not by
ChABC treatment (Fig. 5f). Human α-syn staining in the
contralateral side was absent (Fig. 5f), demonstrating antibody
specificity. We did not find human α-syn engulfed by microglia,
although we did observe human α-syn-positive cells surrounded
by multiple Iba1-positive somas (Fig. 5g), suggesting microglia
can somehow sense damaged or infected cells, a hypothesis
recently demonstrated in experimental stroke39. Moreover,
Iba1 staining showed early microglial invasion into the LB+
PBS-treated SNc, as previously seen for 4-month animals
(Fig. 5h), suggesting that microglial activation takes place shortly
after LB inoculation. Interestingly, LB+Hyase-treated animals
displayed several-fold higher microglial activation in the
ipsilateral SN compared to LB+ PBS, as indicated by Iba1-
positive cell count (1036 ± 261 cells vs. 377 ± 56; Fig. 5i),
Iba1 staining (22.6 ± 5.4% vs. 9.1 ± 1.3%; Fig. 5j) and CD68 stain-
ing (6.3 ± 2.6% vs. 0.4 ± 0.1%; Fig. 5k). Microgliosis was partially
reproduced in the LB+ LMW-HA group, but not in the LB+
ChABC group (Fig. 5i), suggesting that HA small fragments
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Fig. 5 Hyaluronan fragmentation ameliorates LB-induced neurodegeneration by reducing toxic-α-syn load. a Experimental timeline for (b–d).
Hyaluronidase (Hyase) effect lasts only a few days post-injection, since HA is rapidly replenished in vivo. b TH staining shows partial neuroprotection in
the ipsilateral SN 4 months after LB+Hyase inoculation. Scale bar, 200 µm. c, d Stereology revealed a reduction (from 40% to 20%) in dopaminergic cell
loss when LB were co-injected with Hyase or low-molecular weight HA (LMW-HA), but not with chondroitinase ABC (ChABC), suggesting an effect
mediated by HA breakdown. Graphs show TH-positive cell count (c) and ipsilateral/contralateral TH-positive cell ratio (d) (One-way ANOVA with Tukey’s
post-hoc test, n= 4–6 mice). e Experimental timeline for (f–m). Animals were euthanized at the peak of Hyase effect. f Confocal micrographs and
quantification of human α-syn staining in the SN 72 h after LB+Hyase injection show decreased exogenous α-syn load. Scale bar, 50 µm. Color bar
represents fluorescence intensity. g Microglial cells surround a human α-syn-positive cell. Scale bar, 10 µm. h Substantial microglial activation in LB+
Hyase-treated SN shortly after injection, suggesting an early effect of HA cleavage. Scale bar, 100 µm. i–l Quantification of Iba1-positive cells, Iba1, CD68
and HABP levels 72 h after LB inoculation co-injected with various ECM-modification molecules (two-way ANOVA with Holm–Sidak’s post-hoc test, n= 4
mice). m Fractal analysis of HABP staining confirms HA matrix disruption by Hyase (two-way ANOVA with Holm–Sidak’s post-hoc test, n= 4 mice). Data
expressed as mean ± SEM. Source data are provided as a Source data file. See also Supplementary Figs. 7 and 8.
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confirmed HA depletion (10.1 ± 0.7% LB+ PBScontra, 2.3 ± 0.3%
LB+Hyaseipsi; Fig. 5l) whereas fractal analysis detected heavy
HA network disruption 72 h after Hyase injection (Fig. 5m).
Taken together, these results indicate that acute HA depletion,
most certainly via HA fragmentation, exacerbates the early (72 h)
microglial activation observed after LB inoculation and reduces
proteopathic seeds load. These events ultimately result in long-
term neuroprotection (i.e., 4 months).
Hyaluronan depletion affects mostly ECS diffusivity. We next
explored the effect of chronic HA modification on ECS parameters
and on the pathological process. Long-term HA depletion was
achieved by chronic treatment with 4-methylumbelliferone (4MU,
Fig. 6a), a Has inhibitor extensively used in vivo40. HA depletion
was confirmed in blood samples by ELISA and by immunohis-
tochemistry in different brain regions (Fig. 6b, c and Supple-
mentary Fig. 9). First, we checked whether chronic HA depletion
alters ECS local diffusion in the SN of LB-inoculated mice by
SWCNT tracking in acute slices. We observed increased relative
diffusivity in 4MU-treated animals with respect to normal diet, an
increase slightly exacerbated after neurodegeneration (median=
0.025 Ctrl, 0.040 4MU, 0.049 4MU-LB; Fig. 6d, f, g and Supple-
mentary Movie 4). ECS widths were also increased in both 4MU
and 4MU+ LB groups. However, ECS enlargement was much
more pronounced with the additional presence of LB (median=
135 nm Ctrl, 154 nm 4MU, 195 nm 4MU-LB; Fig. 6e, h, i), sug-
gesting that neurodegeneration has more impact on ECS mor-
phology (widths), while ECS diffusivity depends mostly on HA
fluctuation (Fig. 6f vs. 6h). Finally, we examined nigral neurode-
generation at 4 months post-LB inoculation, and we detected a
non-significant trend for neuroprotection in the 4MU-treated
animals with respect to normal diet (35.9 ± 7.6% 4MU-LB, 45.1 ±
6.8% Ctrl-LB; Supplementary Fig. 10a, b), indicating that chronic
HA depletion has milder effects on dopaminergic cell loss than
acute depletion with Hyase, probably due to compensatory
mechanisms. Widespread microgliosis was observed after 1 month
of 4MU-dependent HA depletion (Supplementary Fig. 10c), as
































f g h i
10




























































































200 300 400 5000.0 0.1












































Fig. 6 Hyaluronan depletion increases ECS nanoscale diffusivity more profoundly than ECS width. a Experimental timeline. 4-methylumbelliferone
(4MU) inhibits HA synthesis in vivo. 4MU-based diet started 4 weeks prior to LB-inoculation to deplete HA chronically before the onset of pathology.
b, c Quantification of HA staining in SN of mice (b) or HA content in mouse plasma (c) after 1 month of 4MU or normal diet (two-tailed Student’s t test,
n= 4 mice). d, e ECS relative diffusivity (d) and spatial (e) maps of the nigral ECS in control mice and mice with experimental matrix disruption (4MU) and
experimental+ pathological degradation of the HA matrix (4MU-LB). Scale bars, 2 µm. f Cumulative distributions of ECS relative diffusivities show
increased nanoscale diffusion in the SN of 4MU-treated mice and 4MU-mice after LB-induced neurodegeneration (Kolmogorov–Smirnov test of 4MU vs
4MU-LB, n= 4 mice). g Frequency distributions of nigral ECS Dinst/Dref obtained from 4MU and 4MU-LB-treated mice. h Cumulative distributions of ECS
dimensions show increased ECS width in the SN of 4MU-mice, an effect augmented in 4MU-treated mice injected with LBs (Kolmogorov–Smirnov test of
4MU vs 4MU-LB, n= 4 mice), suggesting that neurodegeneration impacts ECS width, while HA depletion influences mostly ECS diffusivity. i Frequency
distributions of ECS widths show an increased ECS enlargement in the degenerated (LB) and HA-depleted (4MU) SN, with most dimensions exceeding
100 nm. Error bars represent mean ± SEM. Source data are provided as a Source data file. See also Supplementary Figs. 9 and 10.
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both ipsi and contralateral sides 72hs post LB-injection (Supple-
mentary Fig. 10d). Chronic neuroinflammation, rather than acute,
may complicate even further the neuropathological outcome, and
hence it might explain the lack of neuroprotection in the 4MU
model. Taken together, these results indicate that experimental
chronic HA depletion increases ECS width and in particularly
diffusivity, in a similar fashion to pathological (LB-induced) HA
degradation. This confirms that ECS local parameters, and espe-
cially nanoscale diffusion, are inversely related to HA.
Discussion
Unravelling the ECS structure and function represents a techno-
logical challenge due to its nanometric dimensions, and despite
recent remarkable advances2,3,17–19, its precise morphological and
diffusional parameters are still unknown in brain pathology. Here
we explored the ECS nanoscale organization in the SN of adult
mice after LB-induced neurodegeneration, a model of synuclei-
nopathy for PD. Using state-of-the-art technologies, we revealed a
highly heterogeneous ECS displaying localized areas of increased
diffusivity and enlarged dimensions in the degenerated SN. We
have also demonstrated a link between ECS nanoscale parameters,
ECM content and glia. These mice display a degraded hyaluronan
matrix in a context of reactive microglia, while experimental
matrix disruption modified the pathology and increased ECS
width and diffusion. Our results reveal a disorganization of the
brain extracellular microenvironment associated to hyaluronan
remodeling and microglial activation in the parkinsonian SN.
It has been long established that the ECS volume fraction in the
brain ranges between 15 and 20%1,7, and ECS volume changes
have been reported in pathological states1. However, estimating
its exact width has proven more difficult due to experimental
limitations14. Here we provide nanoscale ECS dimensions in
adult parkinsonian SN analyzed by two different methods:
cryofixation-EM and single-nanotube tracking. Both techniques
rendered similar distributions of ECS widths (Figs. 1i and 2g),
with most values falling around the 100 nm mark and an insig-
nificant proportion of widths over 500 nm. These values are in
accordance to a recent report on cryofixed adult mouse cortex17.
Using STED microscopy, Tønnesen et al. described slightly higher
ECS dimensions in organotypic brains slices18, a preparation that
has been shown to display a looser, wider ECS than its adult
counterpart19. Mapping ECS local width revealed a characteristic
channels-and-pools topology, analogous to the interconnected
network of sheets-and-tunnels reported by others using 3D-
reconstruction models of the ECS6,41. We observed a clear trend
for larger ECS volume fractions in the parkinsonian SN. Unu-
sually high ECS volume fractions have been reported in the SN of
other species42, thus an alternative method such as real-time
iontophoresis with tetramethylammonium (RTI-TMA) should
validate these results. Nonetheless, volume fraction is a global
parameter that affects -and it is quantified- over an entire region.
Local width, on the contrary, provides ECS information at nan-
ometer resolution, a scale more in accordance with biological
processes43. In this context, we detected increased local dimen-
sions in the parkinsonian ECS. This increase, found both in
cryofixed and live SN, is at odds with decreased HA levels, con-
sidering that this hygroscopic polymer has been proposed as a
determinant of ECS volume29. We argue that the changes we
observe in ECS dimensions are probably due to the loss of cellular
tissue by neurodegeneration, but also the consequence of dis-
rupted cell attachments associated to matrix degradation. Further
characterization of cell-ECM interactions conducted at the
molecular level are needed to elucidate this phenomenon.
Diffusional parameters are equally augmented in the parkin-
sonian ECS, although they are not spatially correlated to local
changes in ECS width. Diffusion in the brain ECS has been
proposed to be affected by geometry and viscosity3,44, the latter
being mostly determined by macromolecular obstacles. Whether
geometric tortuosity or diffusion barriers have differential weight
influencing molecular diffusion through the ECS, is still a matter
of debate14. According to the restricted diffusion theory,
SWCNTs in LB-inoculated mice should display reduced geo-
metric hindrance due to increased ECS width. Nonetheless, we
present evidence here that regulation of nanoscale diffusivity
might not be exclusively imposed by variations of geometric
constraints. The comparison between 4MU vs 4MU-LB, with
similarly increased diffusion despite larger ECS widths in the
latter, suggests that hyaluronan-mediated hindrance plays a
major role determining ECS diffusivity. We and others have
reported augmented diffusion after ECM removal2,45. Here we
focus on its most abundant component, HA, a viscous polymer
that scaffolds ECM assemblies. Either pathologically-induced
(LB) HA degradation as well as chemically-induced (4MU) HA
depletion rendered similar increase in nanoscale diffusivity. Thus,
we propose HA as a dynamic ECS organizer that determines
diffusivity locally. This concept has profound implications: first,
spatial regulation of HA, either by removal or overproduction,
might establish or modify concentration gradients by locally
altering diffusion (i.e., channeling movement of molecules at a
nanoscale) either transiently or in a long-lasting manner. This
would have repercussions in the specificity of extrasynaptic
communication, which is based on local nanoscopic diffusion
through the ECS1,24. Second, most mathematical models focused
on diffusion or bulk flow address the ECS as an empty space. We
believe that future ECS models would benefit from including
diffusional barriers in addition to topology.
From the vast array of molecules forming the ECM, HA is
probably its most versatile component, given its structural and
signaling properties46. We demonstrate extensive HA degradation
in the SN after neurodegeneration. This occurs without affecting
CSPGs, as reported in human neurodegeneration31 or HA loss
in vivo29. We propose that pathological HA disruption impacts
not only diffusion, but also inflammation. Low-MW-HA is a pro-
inflammatory molecule11, and HA breakdown in the SN might
trigger the release of additional damage-associated molecular
patterns (DAMPs), since matrix metalloproteinases (MMP)
activity is increased by fragmented HA47. We did not find
changes in mRNA levels of neither HA-synthases nor hyalur-
onidases, but detected increased HA phagocytosis by activated
microglia. The significant proportion of HA inclusions found in
control mice suggests that microglia might participate in phy-
siological HA turnover. Nonetheless, this balance seems altered in
the parkinsonian SN, suggesting the existence of a positive
feedback loop microglia-HA. HA internalization is mostly
dependent on CD44 receptor35,48, and its expression is elevated in
LB-inoculated mice, similarly to microglial CD44 upregulation in
other brain disorders35, In pathological states, HA can also be
degraded non-specifically by reactive oxygen species (ROS)49, a
common feature of neurodegeneration, and we cannot exclude
this possibility in our model. The decrease in HA fractal
dimension, which we interpret as a loss of interconnectivity,
might be due not only to HA degradation but also to proteolysis
of HA cross-linkers32 such as tenascins.
Seed-based models such as the LB-inoculated mouse offer the
possibility to study the pathological process at an early stage50.
While the detailed description of the ECS we provide here is
presented as the pathological ECS, our findings have implications
to specific mechanisms of PD and other proteinopathies. The
obvious hypothesis is that increased ECS diffusion might have a
role in the spreading of toxic conformers of α-syn or other pro-
teopathic seeds, and here we show that degrading hyaluronan
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in vivo (i.e. Hyase) reduces α-syn inoculum load. This could be
due to increased clearance of the inoculum through the ECS,
reducing its chance to be internalized by cells, although a quan-
titative model would better clarify this phenomenon. Degradation
of another ECM component (CSPGs) had no effect, ruling out
Hyase-mediated indirect ECM disruption as the mechanism. A
recent report in C. elegans showed that hyaluronidase TMEM2
ameliorates intracellular ER stress modulating pathology51, sug-
gesting another mechanism for HA breakdown-mediated neu-
roprotection. In addition, our results suggest that HA
modification could play a role via modulation of inflammation.
HA fragmentation by Hyase, occurring at the moment of LB-
inoculation, is neuroprotective in our model, triggering a sub-
stantial microglial activation and reducing proteopathic-seeds
load. A plausible explanation is that overstimulation of microglia
by HA breakdown exerts a beneficial pro-inflammatory state that
impairs seeding. In fact, LMW-HA partially reproduced Hyase-
mediated effects in neuroinflammation and α-syn load, and
protected from dopaminergic cell loss. Despite we found no
evidence that activated microglia engulfs α-syn, we detected Iba1-
positive cells surrounding human-α-syn-positive neurons in the
murine SN, suggesting that these cells can sense either aggregated
α-syn52,53 or neuronal damage39. It is possible that toxic-α-syn-
positive cells release injury-related factors such as ATP, which
attracts microglia54. This would also explain microglia invading
the degenerated SNc. Aggregated α-syn can activate microglia55,
upregulate CD44 and enhance migration56. In accordance, we
observed early inflammation triggered by LB inoculation alone,
but to a much lesser extent than in the HA-modified brain,
suggesting that HA fragmentation amplifies this phenomenon.
Either at the synaptic cleft, intracellular calcium microdomains,
or neurotransmitter receptors, there is an increasing need in neu-
roscience to refine probing of biological compartments57. Studying
local changes at the nanoscale, as opposed to global parameters
spanning entire regions, is a paradigm shift in neurobiology that
finds its latest bastion in the ECS. This is the first study exploring
ECS, ECM and glia in an integrative approach within a pathological
context, and provides evidence of a dynamic interplay between
these players. Rephrasing a 50-years-old hypothesis by ECS research
pioneers Schmitt and Sampson58, we propose the term “brain
extracellular microenvironment” to encompass these factors under
one unifying concept to facilitate discussions. Finally, the possibility
to combine nanoscale ECS exploration with ECM, cellular and
subcellular labeling will open new avenues to further understand
brain physiology in health and disease.
Methods
Animals and surgical procedures. LB and noLB fractions were purified from
fresh frozen post-mortem samples of sporadic PD-patients obtained from brains
collected as part of the Brain Donation Program of the Brain Bank GIE NeuroCEB,
run by a consortium of Patients Associations: ARSEP (multiple sclerosis), CSC
(cerebellar ataxias), France Alzheimer and France Parkinson. The consent docu-
ments were signed by the patients themselves or their next of kin in their name, in
accordance with the French Bioethical Laws. The Brain Bank GIE NeuroCEB
(Bioresource Research Impact Factor number BB-0033-00011) has been declared at
the Ministry of Higher Education and Research and has received approval to
distribute samples (agreement AC-2013-1887). Human SNpc was dissected and
homogenized before a sucrose step gradient20 and sonicated for 5 min prior to
in vivo inoculation to disrupt α-synuclein aggregates into oligomeric and fibrillary
fragments. Male 10-weeks-old C57BL/6J mice (Charles River) were unilaterally
injected into the substantia nigra with 2 µl of either Lewy-body (LB) fractions,
containing toxic fibrillary α-synuclein, or noLB fractions, with soluble non-
aggregated α-synuclein. Intranigral inoculations were achieved by stereotactic
surgery (coordinates from bregma: −2.9 mm anteroposterior, 1.3 lateral, and −4.5
dorsoventral) under deep isoflurane anesthesia at a flow rate of 0.4 µl/min with a
30-gauge Hamilton syringe coupled to a microinjection pump (World Precision
Instruments). The needle was left in place for 10 min to avoid leakage. Some
animals were co-injected with 2 µl of LB fractions and either 1 µl (3U) of hyalur-
onidase (Hyase) from Streptomyces hyalurolyticus (Sigma-Aldrich), 0.025U of
chondroitinase ABC (Sigma-Aldrich), low-molecular weight (200 mg/ml) or high-
molecular weight hyaluronan (15 mg/ml, Sigma-Aldrich) or sterile PBS. The
Institutional Animal Care and Use Committee of Bordeaux (CE50) approved
experiments under license #5520-2016052514328805.
4-MU treatment. 6-week-old C57BL/6J mice (Charles River) were fed with normal
mouse chow or mixed with 5% (w/w) 4-methylumbelliferone (4MU, Sigma-
Aldrich), a concentration reported to effectively inhibit hyaluronan production
in vivo systemically59 and in CNS60. The mixture was prepared fresh daily,
including water and 33% of cacao to enhance the palatability of the drug. Animals
were fed with 4-MU for 4 weeks prior to LB inoculation, and kept on this diet until
euthanasia (4 months). Animals were weighted daily during the first month, and
weekly afterwards. Despite initial weight loss in the 4MU-treated animals, mice
recovered after 2 weeks. Animals showed no sign of stress or particular phenotype,
other than weakness of the skin during surgery suture. The Institutional Animal
Care and Use Committee of Bordeaux (CE50) approved experiments under license
#10721-2017071213284522.
High-pressure cryofixation and electron microscopy. Bilaterally LB-inoculated
mice were euthanized by cervical dislocation and brains quickly removed and sliced
(180 µm thickness) in a VT1200S vibratome (Leica Microsystems) in ice-cold aCSF
(see below “acute brain slice preparation” for details). Tissue discs (5 mm diameter)
of substantia nigra (SN) were immediately transferred to a 200 µm-thick aluminum
sample holder (6 mm diameter). Medium was cleared with a filter paper and the
cavity filled with 1-hexadecene. The sample was sandwiched with a flat aluminum
top plate and high-pressure frozen in a HPM100 device (Leica Microsystems). No
more than 10 min elapsed from euthanasia to cryofixation. Samples were kept in
liquid nitrogen until further processing. Since the pathology develops in each
hemisphere independently, SNs were treated separately as individual samples.
Freeze-substitution resin embedding was carried out in an AFS2 unit (Leica
Microsystems). Frozen samples were incubated for 40 h using 0.1% tannic acid in
anhydrous acetone at −90 °C, followed by 12 h of 2% OsO4 in anhydrous acetone
at −90 °C. The temperature was then raised to −30 °C with periodic temperature
transition gradients of 1 °C/h and to −10 °C by 3 °C/h. Samples were then
immersed in Epon resin/anhydrous acetone over 9 h (1/3, 1/1 and 3/1, 3 h each)
whilst temperature increased to 20 °C. Finally, samples were added to 100% Epon
resin at room temperature for 2 h prior to polymerization at 60 °C for 48 h.
Artifact-free tissue was selected in semi-thin (0.5 mm thick) sections stained
with toluidine blue. Ultra-thin sections of selected regions were post-stained with
uranyl acetate (1%) and lead citrate and imaged in a transmission electron
microscope (H7650, Hitachi) equipped with a SC1000 Orius camera (Gatan).
Estimation of ECS dimensions from cryofixation-EM images. ECS was manually
segmented from cryofixed-EM images where membranes were easily discernible
(Supplementary Fig. 2), using an interactive pen tablet (Wacom) and the TrakEM2
plugin in Fiji/ImageJ (NIH)61. Segmented images were binarized, resulting in
individual ECS compartments (Fig. 1d). The ECS volume fraction was estimated by
dividing the area of ECS compartments by the total area of the image.
To estimate the length of ECS compartments, binary images were skeletonized
and the longest shortest path was calculated in ImageJ62. ECS local widths were
calculated by measuring iteratively the diameter of the largest circle fitting each
portion of the ECS compartment, using a 2D implementation of the Local
Thickness plugin (ImageJ). The distribution of pixel values obtained from the
histograms of ECS local thickness maps was converted to dimensional values using
the image pixel size (1.42 nm).
SWCNTs injection and acute brain slice preparation. 1 mg of HiPco-synthesized
carbon nanotubes (from Rice University) was suspended with 50 mg of mono-
functional phospholipid-polyethylene glycol (#mPEG-DSPE-5000, Laysan Bio) in
10 ml of deuterium oxide (Sigma Aldrich). After homogenization for 15 min at
19,000 rpm with a dispersing instrument (IKA T-10 Basic), SWCNTs were further
dispersed via tip sonication (20W for 8 min) and then centrifuged at 800 × g for 60
min to remove nanotube bundles and impurities.
Four months after LB or noLB inoculation, animals underwent a similar
stereotactic surgery where 6 µl of SWCNT solution was injected into the cerebral
lateral ventricle (coordinates from bregma: −0.5mm anteroposterior, 1 mm
mediolateral, −2.4 dorsoventral). The needle was left in place for 10min to avoid
leakage. Animals received buprenorphine (0.1mg/kg) as analgesic and returned to
their cages. 1 h after SWCNT injection, mice were euthanized by cervical dislocation.
Brains were extracted and coronal sections (300 µm thick) were prepared in a Leica
VT1200S vibratome. Slicing was performed in ice-cold low-Na+ low-Ca2+ high-Mg2
+ artificial cerebrospinal fluid (aCSF) solution containing 180mM sucrose, 2.5 mM
KCl, 1.2 mMNaH2PO4, 13mM glucose, 20mMHEPES, 10mMMgSO4 and 0.5 mM
CaCl2. Slices were then transferred to oxygenated aCSF (gassed with 95% O2, 5%
CO2, pH= 7.4) containing 124mM NaCl, 2.5mM KCl, 1.2 mM NaH2PO4, 24mM
NaHCO3, 13mM glucose, 3 mM sodium pyruvate, 2 mM MgSO4 and 2mM CaCl2
and kept at room temperature until imaged within 2 h.
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Near-infrared microscopy. Slices were recorded at 37 °C in a 3D-printed chamber
with oxygenated warm aCSF perfused by a peristaltic pump (Fig. 2b). The overall
quality of the tissue was initially checked with a standard 4× objective and a white
light fiber bundle positioned at 30° above the sample (oblique illumination tech-
nique). SWCNTs with a (6,5) chirality were excited at their K-momentum dark
exciton vibronic sideband63 using a 845 nm laser (Coherent) and imaged with a
long pass 900 nm filter (Semrock) using a water immersion 60× objective (NA 1.0,
Nikon). Images of moving SWCNTs in ECS were collected using a 30 ms exposure
time with an EM-CCD camera (Princeton Instruments). Slices were imaged for no
more than 1 h. The peristaltic pump was turned off during each recording (2–4
min) to minimize sample drift.
Single-nanotube localization analysis. Image analysis was performed using
custom MATLAB (MathWorks) and Python scripts. Briefly, individual diffusing
SWCNTs in the ECS of live brain tissue were super-localized by fitting images with
two-dimensional asymmetric Gaussian functions having arbitrary orientations.
Three consecutive images were averaged for each fit to improve the localization
precision (∼50 nm in water). Slow sample drift was corrected by tracking back-
ground features using a variant of the redundant cross-correlation drift
estimator64,65. Briefly, a region of the image where background features were visible
was initially selected for analysis. For each pair of frames t, u (1 ≤ t, u ≤ T where T is
the total number of frames), the cross-correlation was computed on the region of
frame t to the region on frame u. The maximum of the cross-correlation map
estimates the drift between frames t and u, Δt,u= ru− rt (where rt is the drift at
time t); the position of this maximum is estimated with subpixel accuracy by
quadratic interpolation. Repeating this process over all pair of frames lead to an
overdetermined system of T(T−1)/2 equations, Δ2,1= r2− r1, Δ3,1= r3− r1, Δ3,2=
r3− r2, etc., for the T unknowns r1,…, rT. As previously described elsewhere64,65,
the outlier equations (i.e. inconsistent equations) were found by comparing the
residuals after solving the T(T−1)/2-equation system in a least-squares sense (a
threshold of 1 px was used for analysis). We found that a more accurate estimation
of the drift could be obtained by iteratively repeating the process of solving the
overdetermined system and removing outlier equations until the set of equations
stabilized. Finally, the resulting drift estimate was smoothed using a local window
where the drift estimate on a given frame was weighted according to the number of
non-outlier equations.
Local ECS dimensions and diffusivity from SWCNT images. Drift-corrected
SWCNT coordinates were interconnected to reconstruct individual trajectories.
The SWCNT lengths were estimated using the distribution of the longest axis of the
2D asymmetric Gaussian fits when SWCNT movements were undetectable (i.e.
displacements between images <40 nm) corrected by the exciton diffusion length
(~100 nm)19. The length distribution of the analyzed SWCNTs was centered at
around 500 nm. Super-resolved images of the ECS were computed on 25 nm pixels
by cumulating the SWCNT localizations and convoluting them with a two-
dimensional Gaussian of 50 nm full width at half maxima (FWHM) and unit
amplitude. Areas of SWCNT exploration were calculated by measuring the binary
images of ECS super-resolved maps.
To estimate local ECS dimensions, the shape of the local area explored by
individual SWCNTs along their trajectory was analyzed using a 6-points time-
window19. This time window was chosen at maximum confinement (i.e. when the
shape of the local area is maximally distorted by local ECS dimension as compared
to expected in unconfined environments) as defined by the eccentricity ratio of the
ellipse formed by the SWCNT trajectory (Supplementary Fig. 3). For each
trajectory, analysis of the instantaneous mean square displacement (MSDinst) was
used to estimate the instantaneous diffusion coefficient Dinst. MSD values were
calculated over a sliding window of 450 ms and linear fits were then applied to the
first 90 ms to retrieve values of Dinst. Immobile SWCNTs, characterized by the
plateau shape of their global MSD, were excluded from the analysis
(Supplementary Fig. 3). Local relative diffusivity (Dinst/Dref)3,19 was obtained by
comparing Dinst with the free diffusion of the considered SWCNT in a fluid having





where kB is the Boltzmann constant, T is the temperature of recording, φ is the
SWCNT aspect ratio, and L is the nanotube length. Spatial diffusivity maps were
created by associating local relative diffusivity values with super-localized centroid
positions. Values falling within the same pixel (25 nm) were averaged and
convoluted with a 2D Gaussian of 50 nm FWHM and unit amplitude.
Immunostaining and confocal imaging. Mice were anesthetized with pento-
barbital (100 mg/kg ip) and intracardially perfused with 0.9% saline followed by
ice-cold freshly-prepared 4% paraformaldehyde (PFA) in 0.1 M PB. Brains were
post-fixed for 3 h in 4% PFA and 40 μm-thick vibratome coronal sections were
collected. For visualization of the hyaluronan matrix or CSPGs, slices were blocked
with 1% bovine serum albumin (BSA) in PBS with 0.1% saponin for 1 h, followed
by streptavidin-biotin blocking kit (Vector Labs) for 20 min, and incubated over-
night with either biotynilated-hyaluronic acid binding protein (HABP from bovine
nasal cartilage, Merck-Millipore) or biotynilated Wisteria Floribunda Agglutinin
(WFA, Vector Labs) diluted in blocking solution. Staining was revealed with
Streptavidin-Atto647N (Sigma-Aldrich), with minimum non-specific labeling due
to appropriate blocking of endogenous biotins (Supplementary Fig. 5c). Double or
triple labeling was achieved by re-blocking samples with 4% normal goat serum
and overnight incubation with primary antibodies for the following antigens: Iba1
(019-19741, Wako), CD68 (FA-11, Bio-Rad), TH (LNC1, Merck-Millipore),
human α-synuclein (Syn211, Thermo Fisher). Staining was revealed with appro-
priate secondary antibodies conjugated with Alexa 488 or 594 (Thermo Fisher) and
incubated 30 min with nuclear dye Hoescht 33342 (10 µM, Thermo Fisher). Sec-
tions were mounted on #1.5 coverslips with Mowiol + DABCO and left to dry
overnight in darkness. Confocal images were obtained in a Leica TCS SP8
microscope, maintaining image acquisition settings (laser power, AOTF, detection
parameters) between sessions. Image stacks (pixel size ~100 nm, z-step 0.5 µm)
were acquired with 20X or 63X Plan Apo CS objectives with oil immersion.
Analysis of hyaluronan network and microglia. HABP, Iba1, CD68 and human
α-syn levels were quantified on 12-bit ×63 confocal images acquired from coronal
SN sections, at least 100 µm rostral or caudal to the point of injection. At least
4 slices were quantified per animal (2 rostral and 2 caudal). The area of staining
was calculated by automatic thresholding in Fiji/ImageJ and related to the total area
of the image. Iba1-positive somas were manually counted in ROIs based on the TH
channel and normalized by surface area. For CD68, a mask generated in the Iba1
channel was applied, to ensure quantification of CD68 labeling exclusively inside
microglia. For α-syn levels, the mean gray value of the contralateral side (where no
injection was performed, therefore, no human α-syn staining was possible) was
deemed as background and set as value= 0 for the quantification in the
ipsilateral side.
To quantify hyaluronan network complexity by analysis of fractal dimension,
HABP-TH double immunofluorescence images were segmented in the HABP
channel by thresholding, then binarized and skeletonized in Fiji. Analysis was
spatially restricted by creating a mask in the TH channel and therefore quantifying
only the interstitial matrix of the SNc, where interconnectivity is more evident. Box
counting fractal dimension was calculated with the FractalCount plugin for Fiji/
ImageJ using default parameters. The length of hyaluronan cables was estimated on
skeletonized images by quantifying the longest shortest path of the skeleton.
Hyaluronan engulfment by microglia was quantified manually in images where
Iba1-positive somas were visible in the entirety of the z-stack, and expressed as %
of Iba1-positive cells with hyaluronan inclusions. To ensure quantification of only
sizable HABP-positive clusters inside Iba1 cells, background in the HABP channel
was subtracted and a median filter of 1px was applied to eliminate small staining
artifacts. Colocalization, fluorescence profiles, orthogonal projections, and maximal
intensity projections were performed in Fiji/ImageJ (NIH). Images were linearly
adjusted for brightness and contrast for visualization purposes, applying similar
values to control-treated or contralateral-ipsilateral samples.
Unbiased stereological cell counts. For SN cell counts, every fourth section was
processed for TH immunohistochemistry and counterstained with cresyl violet,
resulting in 6 sections to be counted per animal. Briefly, 40 μm free-floating coronal
sections were blocked 1 h with 1% BSA+ 0.3% Triton X-100 in PBS and incubated
overnight with anti-TH (clone LCN1, Merck-Millipore). Staining was revealed
using anti-mouse HRP EnVision kit (Dako) for 30 min followed by DAB staining
(30 s).
Stereology was performed using the Mercator Pro software (Explora Nova)
coupled to a Leica DM-6000B microscope with a motorized XYZ stage. The
number of neurons in the SN was estimated using the optical fractionator method
and calculated based on the following formula: N= ΣQ− × 1/ssf × 1/asf × t/h,
where N is the estimate of the total number of cells, ΣQ− is the number of objects
counted, ssf is the section sampling fraction, asf is the area sampling fraction, and t/
h is the actual section thickness divided by the height of the dissector.
qPCR. Nigral samples were homogenized in Tri-reagent (Euromedex) and RNA
was isolated using a standard chloroform/isopropanol protocol66. cDNA was
synthesized from 2 μg of total RNA using RevertAid Premium Reverse Tran-
scriptase (Fermentas) and primed with oligo-dT primers (Fermentas) and random
primers (Fermentas). qPCR was performed using a LightCycler 480 Real-Time
PCR System (Roche). qPCR reactions were done in duplicate for each sample,
using transcript-specific primers, cDNA (4 ng) and LightCycler 480 SYBR Green I
Master (Roche) in a final volume of 10 μl. The PCR data were exported and
analyzed using an informatics tool (Gene Expression Analysis Software Environ-
ment) developed at the NeuroCentre Magendie. For the determination of the
reference gene, the Genorm method was used67. Relative expression analysis was
corrected for PCR efficiency and normalized against two reference genes: gapdh
and ubc. The relative level of expression was calculated using the comparative (2
−ΔΔCT) method and expressed as fold-change. Primer sequences are detailed in
Supplementary Table 1.
Thioflavin T assay. To assess the level of aggregation of LB upon contact with
Hyase, we performed a Thioflavin T assay68. Briefly, 5 µl of sonicated LB with or
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without 2 U of Hyase were added to 495 µl of a solution containing 20 mM ThT,
50 mM glycine in water, pH 8.5. Freshly-prepared amyloid-beta was left overnight
at room temperature to oligomerize and used as positive control for aggregation.
Fluorescence was measured every hour in a FLUOstar Optima (BMG Labtech) at a
450/480 nm excitation-emission wavelengths.
Proteinase-K assay. To analyze α-synuclein aggregates in the SN of LB(Hyase)-
inoculated mice we performed a Proteinase-K assay, an enzyme that eliminates
only non-aggregated proteins. Midbrain slices were incubated with 0.1 µg/ml of
Proteinase-K (Sigma-Aldrich) in agitation during 10 min at room temperature and
washed. We next performed standard immunohistochemistry using a pan (rodent
+ human) α-synuclein antibody (syn-1, clone 42, BD Biosciences) and revealed
with HRP EnVision Kit (Dako) and DAB. No-PK slices were processed in parallel
as a positive control for α-synuclein immunohistochemistry.
ELISA. Hyaluronan content was quantified in blood samples from Ctrl and 4MU-
treated mice using the Hyaluronan Quantikine ELISA Kit (R&D Systems)
according to manufacturer instructions. Briefly, blood was extracted from mice by
cardiac puncture with a 1 ml syringe primed with EDTA 15% and transferred to
polypropylene tubes. Plasma was separated by centrifugation and stored at −80 °C
until further use. Hyaluronan content was determined in 40x dilutions of plasma
sample by colorimetric ELISA in a FLUOstar Optima (BMG Labtech) plate reader.
Results were interpolated into a standard curve using a 4-PL curve fit corrected for
background absorbance.
Statistics and reproducibility. Methodologies that are routinely used in our
laboratories were successfully reproduced according to our previous publications:
LB-induced neurodegeneration, single-nanotube tracking, hyaluronan, and
microglia analysis. For newly acquired methodologies (cryofixation-EM, 4MU
treatment, Hyase and ChABC injection), we conducted pilot experiments to vali-
date those methods, which were successfully replicated in this study. The key
finding of increased ECS width and diffusion in LB-inoculated mice was replicated
in two completely different experiments performed independently that achieved
the same conclusion. Statistical analyses were performed in GraphPad Prism
7.0 software or MATLAB. Datasets were initially tested for normal distribution
with D’Agostino-Pearson normality test. Normal populations were analyzed by
unpaired two-tailed t-test (paired for contralateral vs ipsilateral comparisons) or
One or Two-way ANOVA followed by Holm–Sidak post-hoc test, depending on
the number of variables. Continuous datasets (i.e. with a large number of data
points) with non-normal distributions were analyzed by Kolmogorov–Smirnov
(KS) test comparing cumulative distributions. For all statistical tests, the level of
significance was set to P < 0.05. Exact P values are reported in each figure. In KS
tests for large datasets, an approximate P value was calculated. The number of
replicates (n) is reported in figure legends. Discrete data are represented as mean ±
SEM unless specified otherwise. Continuous datasets are represented as relative
frequency or cumulative distributions.
Availability of unique biological samples. LB and noLB fractions from PD
patients are obtained from limited material. The authors would gladly extract them
from the provided samples.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this paper.
Data availability
The data that support the findings of this study are available from the corresponding
authors upon reasonable request. Source data are provided with this paper.
Code availability
Customs scripts and software code generated for this paper are available from the
corresponding authors upon reasonable request.
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